BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17317512)

  • 1. Response to "Getting the right message".
    Januzzi JL; Camargo CA; Tung R
    Ann Emerg Med; 2007 Mar; 49(3):381-3; discussion 383; author reply 384. PubMed ID: 17317512
    [No Abstract]   [Full Text] [Related]  

  • 2. On "Getting the right message".
    Collins SP
    Ann Emerg Med; 2007 Mar; 49(3):383-4; author reply 384. PubMed ID: 17317514
    [No Abstract]   [Full Text] [Related]  

  • 3. Getting the right message: avoiding overly optimistic interpretations of the scientific literature.
    Schriger DL
    Ann Emerg Med; 2006 Jul; 48(1):75-6. PubMed ID: 16781922
    [No Abstract]   [Full Text] [Related]  

  • 4. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
    Lamb EJ; Vickery S; Price CP
    J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
    [No Abstract]   [Full Text] [Related]  

  • 5. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

  • 6. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; Cannon CP; Francis G; Jesse RL; Morrow DA; Newby LK; Storrow AB; Tang WH; Pagani F; Tate J; Ordonez-Llanos J; Mair J; ;
    Circulation; 2007 Jul; 116(5):e95-8. PubMed ID: 17630411
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pro: Natriuretic peptides as diagnostic tool. The analysis should be a routine in heart failure diagnosis].
    Dahlström U; Alehagen U
    Lakartidningen; 2006 Mar 22-28; 103(12):927-9. PubMed ID: 16618036
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 9. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 10. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 13. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH; Apple FS; Ravkilde J; Wu AH;
    Circulation; 2007 Jul; 116(5):e99-109. PubMed ID: 17630410
    [No Abstract]   [Full Text] [Related]  

  • 14. B-type natriuretic peptide as a marker of heart failure: Not so specific after all?
    Marshall W; Orlando R
    Crit Care Med; 2006 Aug; 34(8):2249. PubMed ID: 16883197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cut-off values of BNP and NT-BNP for diagnosis of heart failure in emergency service].
    Akpinar O; Kanadaşi M; Ilgenli TF
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):395-6. PubMed ID: 17162299
    [No Abstract]   [Full Text] [Related]  

  • 16. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in heart failure with a normal ejection fraction.
    Cleland JG; Taylor J; Tendera M
    N Engl J Med; 2007 Aug; 357(8):829-30. PubMed ID: 17715420
    [No Abstract]   [Full Text] [Related]  

  • 19. Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design?
    Maisel A
    J Am Coll Cardiol; 2009 Dec; 55(1):61-4. PubMed ID: 20117365
    [No Abstract]   [Full Text] [Related]  

  • 20. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'?
    van Kimmenade RR; Pinto Y; Januzzi JL
    Eur Heart J; 2007 Dec; 28(24):2960-1. PubMed ID: 17984131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.